CAS: 1111556-37-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 1-N-(1-propyl-1H-1,3-benzodiazol-2-yl)benzene-1,3-dicarboxamide REF: IN-DA01DUZBCAS: 1111556-37-6 | 98% | 57.00 €~551.00 € | Wed 26 Mar 25 |
 | Takinib REF: TM-T4264CAS: 1111556-37-6 | 98.47% - 99.18% | 50.00 €~328.00 € | Wed 02 Apr 25 |
 | Takinib REF: 3D-LUB55637CAS: 1111556-37-6 | Min. 95% | 109.00 €~2,213.00 € | Wed 07 May 25 |
1-N-(1-propyl-1H-1,3-benzodiazol-2-yl)benzene-1,3-dicarboxamide
CAS:1111556-37-6
Formula:
C18H18N4O2
Purity:
98%
Molecular weight:
322.3611
Ref: IN-DA01DUZB
| 1mg | 57.00 € | ||
| 5mg | 104.00 € | ||
| 10mg | 112.00 € | ||
| 50mg | 192.00 € | ||
| 100mg | 323.00 € | ||
| 250mg | 515.00 € |
Estimated delivery in United States, on Wednesday 26 Mar 2025
Takinib
CAS:1111556-37-6
Takinib (EDHS-206) is a specific and effective TAK1 inhibitor(IC50= 9.5 nM).
Formula:
C18H18N4O2
Purity:
98.47% - 99.18%
Color and Shape:
Solid
Molecular weight:
322.36
Ref: TM-T4264
| 5mg | 72.00 € | ||
| 10mg | 124.00 € | ||
| 25mg | 219.00 € | ||
| 50mg | 328.00 € |
Estimated delivery in United States, on Wednesday 2 Apr 2025
Takinib
Controlled ProductCAS:1111556-37-6
Takinib is a small molecule that is being developed as a treatment for inflammatory bowel …
Formula:
C18H18N4O2
Purity:
Min. 95%
Molecular weight:
322.36 g/mol
Ref: 3D-LUB55637
| 50mg | 746.00 € | ||
| 500mg | 2,213.00 € |
Estimated delivery in United States, on Wednesday 7 May 2025
